Posted inlatest
Marstacimab Hemophilia Treatment Approved for Ages 12+
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Marstacimab (Hympavzi), marking a major advancement in Marstacimab hemophilia treatment for patients aged 12…